Q4 2015 Holdings
Filed 2016-02-16 | 41 holdings | $75.4M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2016-05-24) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $53.0M | 562,697 | 70.2% |
| BioCryst Pharmaceuticals Inc(BCRX) | COM | 09058V103 | $20.4M | 1,973,108 | 27.0% |
| Anika Therapeutics Inc(ANIK)A | COM | 035255108 | $1.0M | 27,500 | 1.4% |
| Allscripts Healthcare Solutions Inc(MDRX)A | COM | 01988P108 | $738.0K | 48,000 | 1.0% |
| La Jolla Pharmaceutical Co(LJPC)A | COM PAR $.0001 2 | 503459604 | $29.3K | 1,084,416 | 9.7% |
| Omeros Corp(OMER) | COM | 682143102 | $28.1K | 1,785,502 | 0.0% |
| Kite Pharma Inc | COM | 49803L109 | $25.3K | 411,143 | 0.0% |
| Dicerna Pharmaceuticals Inc(DRNAUSD) | COM | 253031108 | $23.4K | 1,975,229 | 0.0% |
| Achillion Pharmaceuticals Inc(ACHNEUR) | COM | 00448Q201 | $21.1K | 1,951,922 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR)A | COM | 60468T105 | $12.2K | 385,456 | 4.0% |
| Atara Biotherapeutics Inc.(ATRAGBX) | COM | 046513107 | $11.2K | 425,852 | 0.0% |
| Five Prime Therapeutics Inc(FPRX) | COM | 33830X104 | $10.5K | 252,452 | 0.0% |
| Celldex Therapeutics IncA | NEW COM | 15117B103 | $10.0K | 637,238 | 3.3% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $9.9K | 2,173,267 | 0.0% |
| Symmetry Surgical Inc | COM | 87159G100 | $7.9K | 863,264 | 0.0% |
| Bristol-Myers Squibb Co(BMY)A | COM | 110122108 | $7.5K | 109,701 | 2.5% |
| Corium International Inc | COM | 21887L107 | $5.9K | 730,031 | 0.0% |
| Global Blood Therapeutics Inc | COM | 37890U108 | $5.6K | 171,898 | 0.0% |
| Dyax CorpA | COM | 26746E103 | $4.4K | 115,795 | 1.4% |
| Regenxbio Inc(RGNX)A | COM | 75901B107 | $3.7K | 221,326 | 1.2% |
| Lipocine Inc | COM | 53630X104 | $2.8K | 216,414 | 0.0% |
| Accelerate Diagnostics IncA | COM | 00430H102 | $2.3K | 107,467 | 0.8% |
| Invuity Inc | COM NEW | 46187J205 | $1.8K | 202,808 | 0.6% |
| CytRx CorpA | COM PAR $.001 | 232828509 | $1.2K | 470,576 | 0.4% |
| Masimo Corp(MASI)A | COM | 574795100 | $1.1K | 25,900 | 0.0% |
| Biopharmx Corp | COM | 09072X101 | $563 | 370,636 | 0.2% |
| Genomic Health Inc(GHDX)A | COM | 37244C101 | $528 | 15,000 | 0.0% |
| Natera Inc(NTRA)A | COM | 632307104 | $342 | 31,693 | 0.0% |
| bluebird bio IncA | COM | 09609G100 | $340 | 5,300 | 0.0% |
| Nivalis Therapeutics Inc | COM | 65481J109 | $232 | 30,000 | 0.1% |
| T2 Biosystems Inc. CmnA | COM | 89853L104 | $229 | 20,900 | 0.0% |
| Veracyte Inc(VCYT)A | COM | 92337F107 | $180 | 25,000 | 0.0% |
| Endologix IncA | COM | 29266S106 | $149 | 15,000 | 0.0% |
| Vivo 01/15/2016 Call 20(MR4)Call | COM | 589584101 | $110 | 1,252 | 0.0% |
| Adaptimmune Therapeutics(ADAPY)A | SPONDS ADR | 00653A107 | $85 | 7,055 | 0.0% |
| Nvro 05/20/2016 PUT 50(NVROEUR)Put | COM | 64157F103 | $37 | 142 | 0.0% |
| Berkshire Hathaway Inc(BRK/B) | CL B NEW | 084670702 | $7 | 50 | 0.0% |
| USO 01/15/2016 Call 25Call | Units | 91232N108 | $7 | 13,850 | 0.0% |